To define the consequence of MMP-14 blockade within the TME, we examined markers of tumor vasculature (CD31), hypoxia (CA9), and a marker of anti-tumor M1 tumor-associated macrophages (TAMs; iNOS). The gene discussed is MMP14; the disease is neoplasm.